Cargando…
Metabolic alterations in plasma from patients with familial and idiopathic Parkinson’s disease
The research of new biomarkers for Parkinson’s disease is essential for accurate and precocious diagnosis, as well as for the discovery of new potential disease mechanisms and drug targets. The main objective of this work was to identify metabolic changes that might serve as biomarkers for the diagn...
Autores principales: | Yakhine-Diop, Sokhna M.S., Morales-García, José A., Niso-Santano, Mireia, González-Polo, Rosa A., Uribe-Carretero, Elisabet, Martinez-Chacon, Guadalupe, Durand, Sylvere, Maiuri, Maria Chiara, Aiastui, Ana, Zulaica, Miren, Ruíz-Martínez, Javier, López de Munain, Adolfo, Pérez-Tur, Jordi, Pérez-Castillo, Ana, Kroemer, Guido, Bravo-San Pedro, José M., Fuentes, José M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521510/ https://www.ncbi.nlm.nih.gov/pubmed/32903216 http://dx.doi.org/10.18632/aging.103992 |
Ejemplares similares
-
The paradigm of protein acetylation in Parkinson’s disease
por: Yakhine-Diop, Sokhna M.S., et al.
Publicado: (2019) -
Toxicity of Necrostatin-1 in Parkinson’s Disease Models
por: Alegre-Cortés, Eva, et al.
Publicado: (2020) -
Acetylome in Human Fibroblasts From Parkinson's Disease Patients
por: Yakhine-Diop, Sokhna M. S., et al.
Publicado: (2018) -
Changes in Liver Lipidomic Profile in G2019S-LRRK2 Mouse Model of Parkinson’s Disease
por: Corral Nieto, Yaiza, et al.
Publicado: (2023) -
Loss of KEAP1 Causes an Accumulation of Nondegradative Organelles
por: Uribe-Carretero, Elisabet, et al.
Publicado: (2022)